TRIMTECH Therapeutics

Private

CambridgeHealthcare & Life Scienceshttps://trimtechtherapeutics.com/

Last Round

Seed

Jun 23, 2026

Total Funding Raised

$61M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

TRIMTECH Therapeutics is a biotechnology company that is developing a targeted protein degradation platform designed to address neurodegenerative diseases by degrading toxic protein aggregates.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

targeted protein degradationTPDsmall molecule degradersprotein aggregate degradationTRIMTACsneurodegenerative diseaseTRIM21 ligaseaggregate-selective degradersdrug discoveryAlzheimer's diseaseParkinson's diseaseHuntington's diseasepreclinical biotechinflammatory diseaseE3 ubiquitin ligase

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TRIMTECH Therapeutics Comps

Public and private peers based on sector, stage, and business model.

TRIMTECH Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TRIMTECH Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 23, 2026
Seed	Mar 5, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Nicki Thompson

Chief Executive Officer

Executive Team

Julia Jones

Fractional CFO

Executive Team

TRIMTECH Therapeutics Investors

Notable investors and investment history

TRIMTECH Therapeutics investors
Investor	Rounds
MP Healthcare Venture Management	Seed
Start Codon	Seed
Cambridge Enterprise Ventures	Seed
BGF	Seed
M Ventures	Seed
Cambridge Innovation Capital	Seed
Johnson & Johnson Innovation - JJDC, Inc.	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 23, 2026
$14M round led by Johnson & Johnson Innovation - JJDC, Inc. and BGF.
May 18, 2026
Monthly visitors increased 814% MoM, reaching 631.

View all signals

TRIMTECH Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

TRIMTECH Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TRIMTECH Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge

Employee Range21

Year Founded2023

Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.